AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, will attend the Jefferies Global Healthcare Conference in London from 17 to 20 ...
SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback